Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mohammad Basabrain"'
Autor:
Sawsan S. Alamri, Khalid A. Alluhaybi, Rowa Y. Alhabbab, Mohammad Basabrain, Abdullah Algaissi, Sarah Almahboub, Mohamed A. Alfaleh, Turki S. Abujamel, Wesam H. Abdulaal, M-Zaki ElAssouli, Rahaf H. Alharbi, Mazen Hassanain, Anwar M. Hashem
Publikováno v:
Frontiers in Microbiology, Vol 12 (2021)
The ongoing global pandemic of coronavirus disease 2019 (COVID-19) calls for an urgent development of effective and safe prophylactic and therapeutic measures. The spike (S) glycoprotein of severe acute respiratory syndrome-coronavirus (SARS-CoV-2) i
Externí odkaz:
https://doaj.org/article/f06cd1e46e344052adf163bca47a890d
Cellular and Humoral Immunogenicity of a Candidate DNA Vaccine Expressing SARS-CoV-2 Spike Subunit 1
Autor:
Khalid A. Alluhaybi, Rahaf H. Alharbi, Rowa Y. Alhabbab, Najwa D. Aljehani, Sawsan S. Alamri, Mohammad Basabrain, Rehaf Alharbi, Wesam H. Abdulaal, Mohamed A. Alfaleh, Levi Tamming, Wanyue Zhang, Mazen Hassanain, Abdullah Algaissi, Adel M. Abuzenadah, Xuguang Li, Anwar M. Hashem
Publikováno v:
Vaccines, Vol 9, Iss 8, p 852 (2021)
The urgent need for effective, safe and equitably accessible vaccines to tackle the ongoing spread of COVID-19 led researchers to generate vaccine candidates targeting varieties of immunogens of SARS-CoV-2. Because of its crucial role in mediating bi
Externí odkaz:
https://doaj.org/article/a694ee371f3e485aa6ae7913ea876395
Autor:
Rowa Y Alhabbab, Abdullah Algaissi, Ahmed Bakr Mahmoud, Almohanad A Alkayyal, Sawsan Al-Amri, Mohamed A Alfaleh, Mohammad Basabrain, Roua Abdullah Alsubki, Ibrahim S Almarshad, Abdulelah M Alhudaithi, Omar A Al Gafari, Yasser A Alshamlan, Hassan M Aldossari, Mohammed M Alsafi, Abdullah Bukhari, Wael Bajhmom, Ziad A Memish, Waleed S Al Salem, Anwar M Hashem
Publikováno v:
Clinical Infectious Diseases. 76:e308-e318
Background The Middle East respiratory syndrome coronavirus (MERS-CoV) is a highly pathogenic zoonotic betacoronavirus and a global public health concern. Better undersetting of the immune responses to MERS-CoV is needed to characterize the correlate
Autor:
Rowa Y, Alhabbab, Abdullah, Algaissi, Ahmed Bakr, Mahmoud, Almohanad A, Alkayyal, Sawsan, Al-Amri, Mohamed A, Alfaleh, Mohammad, Basabrain, Roua Abdullah, Alsubki, Ibrahim S, Almarshad, Abdulelah M, Alhudaithi, Omar A Al, Gafari, Yasser A, Alshamlan, Hassan M, Aldossari, Mohammed M, Alsafi, Abdullah, Bukhari, Wael, Bajhmom, Ziad A, Memish, Waleed, Alsalem, Anwar M, Hashem
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
The Middle East respiratory syndrome coronavirus (MERS-CoV) is a highly pathogenic zoonotic betacoronaviruses and a global public health concern. Better undersetting of the immune responses to MERS-CoV is needed to characterize the correlates of prot